Results 31 to 40 of about 516,590 (413)

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events [PDF]

, 2010
Background An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in comparison with placebo in previous Cochrane reviews.
Aalbers, Aalbers, Altman, Barnes, Beach, Bleecker, Busse, Cates, Cates, Cates, Cates, Cates, Dahl, Ducharme, Ducharme, Ducharme, Giembycz, Higgins, Lasserson, Lipworth, Nelson, Ni Chroinin, Papi, Ringdal, Salpeter, Tamminen, Walters, Walters   +27 more
core   +2 more sources

Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia

American Journal of Hematology, Volume 98, Issue 1, Page 122-130, January 2023., 2023
Abstract Major options for second‐line therapy in adults with chronic immune thrombocytopenia (ITP) include splenectomy, rituximab, and thrombopoietin receptor agonists (TRAs). The American Society of Hematology guidelines recommend rituximab over splenectomy, TRAs over rituximab, and splenectomy or TRAs while noting a lack of evidence on the cost ...
George Goshua, Pranay Sinha, Natalia Kunst, Lauren Pischel, Alfred Ian Lee, Adam Cuker   +5 more
wiley   +1 more source

Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.

Journal of Clinical Investigation, 2020
BACKGROUNDCorticosteroids are widely used in patients with COVID 19, although their benefit-to-risk ratio remains controversial.METHODSPatients with severe COVID-19-related acute respiratory distress syndrome (ARDS) were included from December 29, 2019 ...
Jiao Liu, S. Zhang, Xuan Dong, Zhongyi Li, Qiang-hong Xu, Huibin Feng, Jing Cai, Sisi Huang, Jun Guo, Lidi Zhang, Yizhu Chen, Wei Zhu, Hangxiang Du, Yongan Liu, Tao Wang, Limin Chen, Zhenliang Wen, D. Annane, J. Qu, Dechang Chen   +19 more
semanticscholar   +1 more source

The cost of systemic corticosteroid-induced morbidity in severe asthma : a health economic analysis [PDF]

, 2017
The study data-set was supported by the Respiratory Effectiveness Group through their academic partnership with Optimum Patient Care.
Barry, L E, Heaney, L G, O'Neill, C, Price, D, Sweeney, J   +4 more
core   +3 more sources

Romiplostim use in pregnant women with immune thrombocytopenia

American Journal of Hematology, Volume 98, Issue 1, Page 31-40, January 2023., 2023
Abstract Treatment for immune thrombocytopenia (ITP) in pregnancy is hampered by the lack of fetal safety evidence of maternally‐administered medications. The Pregnancy Surveillance Program (PSP) collected patient information from 2017–2020 for pregnancy, birth outcomes, and adverse events (AEs) for 186 women exposed to romiplostim from 20 days before ...
James B. Bussel, Nichola Cooper, Tatiana Lawrence, Marc Michel, Emilie Vander Haar, Kejia Wang, Hongmei Wang, Hossam Saad   +7 more
wiley   +1 more source

Effect of intra-articular injection of corticosteroid in the patients with osteoarthritis of the knee – A hospital-based cross-sectional study

Journal of Pharmacy and Bioallied Sciences, 2021
Background: Osteoarthritis (OA) of the peripheral joints is frequently related with physical disability and decline in health-related quality of life, deciphering into a significant burden on people and humankind.
Rajeev Reddy Kikkuri, Viveksheel Kashyap, Alka Upadhay, Vaibhav Kumar, Karri Sandeep Reddy, Richa Singhal   +5 more
doaj   +1 more source

Corticosteroids for pneumonia [PDF]

Cochrane Database of Systematic Reviews, 2017
Pneumonia is a common and potentially serious illness. Corticosteroids have been suggested for the treatment of different types of infection, however their role in the treatment of pneumonia remains unclear. This is an update of a review published in 2011.To assess the efficacy and safety of corticosteroids in the treatment of pneumonia.We searched the
Stern, A., Skalsky, K., Avni, T., Carrara, E., Leibovici, L., Paul, M.   +5 more
openaire   +3 more sources

Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management

American Journal of Hematology, Volume 98, Issue 1, Page 193-209, January 2023., 2023
Abstract Disease Overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). Diagnosis The diagnosis of MF or SS requires the integration of clinical and histopathologic data.
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox   +2 more
wiley   +1 more source

A clinicopathological study on IgG4-related ophthalmic disease [PDF]

International Journal of Ophthalmology, 2018
AIM: To investigate clinicopathological features of immunoglobulin G4-related ophthalmic disease (IgG4-ROD), and analyze the recurrence rates following systemic corticosteroid administration.
Yuka Suimon, Satoru Kase, Kan Ishijima, Hiromi Kanno-Okada, Susumu Ishida   +4 more
doaj   +1 more source

Transmission factors and exposure to infections at work and invasive pneumococcal disease

American Journal of Industrial Medicine, Volume 66, Issue 1, Page 65-74, January 2023., 2023
Abstract Background Working in close contacts with coworkers or the general public may be associated with transmission of invasive pneumococcal disease (IPD). We investigated whether crowded workplaces, sharing surfaces, and exposure to infections were factors associated with IPD.
Kjell Torén, Maria Albin, Magnus Alderling, Linus Schiöler, Maria Åberg   +4 more
wiley   +1 more source